Changing epidemiology of Helicobacter pylori in Asia

Journal of Digestive Diseases

Volumn 9, Issue 4, 2008, Pages 186-189

  Tan, Huck J ^a   Goh, K L ^b  

^a Sunway Medical Centre   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Gastroesophageal reflux disease; Helicobacter pylori; Pepticulcer disease; Prevalence; Qastric cancer

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ASIA; CANCER INCIDENCE; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; HYGIENE; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; STOMACH CANCER;

ASIA; ENDOSCOPY, GASTROINTESTINAL; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; STOMACH NEOPLASMS;

EID: 55149118740     PISSN: 17512972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2008.00344.x     Document Type: Review

References (37)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5.
2. Wong BCY, Lam SK, Wong WM et al. Helicobacter pylori eradication to prevent gastric cancer in a high risk region of China: A randomized controlled trial. JAMA 2004; 291: 187-94.
3. You WC, Brown LM, Zhang L et al. Randomised double blind factorial trial of three treatments to reduce the prevalence precancerous gastric lesions. J Natl Canc Inst 2006; 98: 974-83.
4. Fujisawa T, Kumagai T, Akamatsu T, Kivosawa K, Matsunaga Y. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol 1999; 94: 2094-9.
5. Yim JY, Kim N, Choi SH et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007; 12: 333-40.
6. Chen J, Bu XL, Eang QY, Hu PJ, Chen MH. Decreasing seroprevalence of Helicobacter pylori infection during 1993-2003 in Guangzhou, southern China. Helicobacter 2007; 12: 164-9.
7. Chen SL, Xiao SD. Seroepidemiological comparison of Helicobacter pylori infection rates in Shanghai urban districts in 1990 and 2001. Chin J Dig Dis 2003; 4: 40-4.
8. Wong SN, Sollano JD, Chan MM et al. Changing trends in peptic ulcer prevalence in a tertiary care setting in the Philippines: A seven-year study. J Gastroenterol Hepatol 2005; 20: 628-32.
9. Xia B, Xia HHX, Ma CW et al. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment Pharmacol Ther 2005; 22: 243-9.
10. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol 2005; 100: 1923-8.
11. Xia HHX, Phung N, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci 2001; 46: 2716-23.
12. Jang HJ, Choi MH, Shin WG et al. Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study. Dig Dis Sci 2008; 53: 1527-31.
13. Goh KL. Prevalence of and risk factors for Helicobacter pylori infection in a multiracial dyspeptic Malaysian undergoing endoscopy. J Gastroenterol Hepatol 1997; 12: S29-35.
14. Mahadeva S, Raman MC, Ford AC, Follows M, Axon ATR, Goh KL, Moayyedi P. Gastroesophageal reflux is more prevalent in western dyspeptics; a prospective comparison of British and South East Asian patients with dyspepsia. Aliment Pharmacol Ther 2005; 21: 1483-90.
15. Manuel D, Cutler A, Goldstein J, Fennertys MB, Brown K. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications. Aliment Pharmacol Ther 2007; 25: 1423-7.
16. Ong TZ, Hawkey CJ, Ho KY. Non steroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: A prospective study. J Clin Gastoenterol 2006; 40: 795-800.
17. Nishikawa K, Sugiyama T, Kato M et al. Non- Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 2000; 12: 635-40.
18. Hung LC, Ching JY, Sung JJ et al. Long-term outcome of Helicobacter pylori -negative idiopathic bleeding ulcers. A prospective cohort study. Gastroenterology 2005; 129: 1845-50.
19. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: A meta-analysis. Am J Gastroenterol 2007; 102: 1789-98.
20. Furukawa N, Iwakiri R, Koyama T et al. Proportion of reflux esophagitis in 6010 Japanese adults: Prospective evaluation by endoscopy. J Gastroenterol 1999; 34: 441-4.
21. Inamori M, Tagawa J, Nagase H et al. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles Classification. J Gastroenterol Hepatol 2003; 18: 172-6.
22. Rosaida MS, Goh KL. Gastroesophageal reflux disease, reflux esophagitis and non erosive reflux disease in a multiracial Asian population: A prospective, endoscopy based study. Eur J Gastroenterol Hepatol 2004; 16: 495-501.
23. Kang JY, Ho KY. Different prevalences of reflux oesophagitis and hiatal hernia among dyspeptic patients in England and Singapore. Eur J Gastroenterol Hepatol 1999; 11: 845-50.
24. Goh KL, Chang CS, Fock KM et al. Gastroesophageal reflux disease in Asia. J Gastroenterol Hepatol 2000; 15: 230-8.
25. Pan GZ, Xu GM, Ke MY et al. Epidemiological study of symptomatic gastroesophageal reflux disease in China: Beijing and Shanghai. Chin J Dig Dis 2000; 1: 2-8.
26. Chang CS, Poon SK, Lien HC, Chen GH. The incidence of reflux esophagitis among Chinese. Am J Gastroenterol 1997; 92: 668-71.
27. Kang JY, Tay HH, Yap I et al. Low frequency of endoscopic esophagitis in Asian patients. J Clin Gastroenterol 1993; 16: 70-3.
28. Sollano JD, Wong SN, Gamutan TA et al. Erosive esophagitis in the Philippines: A comparison between two time periods. J Gastroenterol Hepatol 2007; 22: 1650-5.
29. Labenz J, Blum AL, Bayerdorffer E et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
30. Wu JC, Sung JJ, Ng EK et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: A study from the East. Am J Gastroenterol 1999; 94: 1790-4.
31. Wu JC, Chan FK, Ching JY et al. Effect of Helicobacter pylori eradication on treatment of gastroesophageal reflux disease: A double blind, placebo-controlled, randomized trial. Gut 2004; 53: 174-9.
32. Haruma K Influence of Helicobacter pylori on gastroesophageal reflux disease in Japan [Review Article]. Aliment Pharmacol Ther 2004; 20 (Suppl. 8): 40-4.
33. Sasaki A, Haruma K, Manabe N et al. Long-term observation of reflux esophagitis developing after Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2003; 17: 1529-34.
34. Goh KL. Obesity and increasing gastroesophageal reflux disease in Asia. J Gastroenterol Hepatol 2007; 22: 1557-8.
35. Graham DY, Adam E, Reddy GT et al. Seroepidemiology of Helicobacter pylori in India. Dig Dis Sci 1991; 36: 1084-8.
36. Gill HH, Majmudar P, Shankaran K et al. Age-related prevalence of Helicobacter pylori antibodies in Indian subjects. Indian J Gastroenterol 1994; 13: 92-4.
37. Forman D, Sitas F, Newell DG et al. Geographic association of Helicobacter pylori prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608-11.